Vircell VirClia® Aspergillus Galactomannan Ag test

Products are for professional/laboratory use only.  Over 30 million people are at risk of invasive aspergillosis each year due to use of corticosteroids, chemotherapy or other immunosuppressive agents, and over 300,000 patients develop it annually.¹

Timely diagnosis and early initiation of therapy strongly influence outcome for patients at risk of invasive fungal infections.

Vircell VirClia® Aspergillus Galactomannan Ag test

• Fully automated antigen test on the VirClia® instruments
• Ready to use reagents
• Flexibility to run only 1 or multiple samples at a time
• Eliminate delay in results due to batch testing
• Results in 1 hour
• Sample type: serum and Bronchoalveolar Lavage (BAL)
• Shelf life 15 months from manufacturing

References

http://www.life-worldwide.org/fungal-diseases/invasive-aspergillosis

Go Back